Oxybutynin Chloride
Product Images NDC 71610-347

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 71610-347). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 10 mg (71610 0347 30)

Oxybutynin Chloride ER USP label for 10 mg tablets, 30 count, product NDC 71610-0347-30. The label states storage instructions between 20-25°C, dispensing in a tight, light-resistant container, and keeping out of reach of children. Manufactured by Aseana Pharmaceuticals of NY and packed by Aphena Pharma Solutions in Cookeville, TN. Includes a barcode and lot and expiration dates.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

The Structural Formula Of Oxybutynin Chloride (Oxybutynin Chloride 01)

Chemical structure diagram of Oxybutynin Chloride showing its molecular components, including aromatic rings, an ester linkage, and an alkylamino side chain bonded to hydrochloride (HCl).*

FDA Label Image

Figure 1: Mean R-oxybutynin Plasma Concentrations Following A Single Dose Of Oxybutynin Chloride 10 mg And Oxybutynin 5 mg Administered Every 8 Hours (n=23 For Each Treatment). (Oxybutynin Chloride 02)

A line graph depicting mean plasma R-Oxybutynin concentration (ng/mL) over 24 hours. It compares two dosing regimens of Oxybutynin Chloride: 10 mg once daily (QD) and 5 mg three times daily (TID), with concentrations plotted against time in hours (h). Error bars indicate variability at each time point.*

FDA Label Image

The Structural Formula Of Mean Steady-state (± Sd) R-oxybutynin Plasma Concentrations Following Administration Of 5 To 20 mg Oxybutynin Chloride Once Daily In Children Aged 5 To 15. Plot Represents All Available Data Normalized To An Equivalent Of Oxybutynin Chloride 5 mg Once Daily. (Oxybutynin Chloride 03)

A line graph showing the mean R-Oxybutynin plasma concentration (ng/mL) over time (hours). The y-axis ranges from 0 to 2.0 ng/mL, and the x-axis ranges from 0 to 24 hours. The graph includes data points with error bars indicating variability at each time point, showing a peak around 4 to 6 hours and a decline thereafter.*

FDA Label Image

Mean Change (sd) In Episodes Per Week From Baseline (Oxybutynin Chloride 04)

A horizontal bar chart comparing the mean change (±SD) in episodes per week from baseline for Oxybutynin Chloride and placebo. The chart shows numerical values along the x-axis ranging from -40 to 40, with separate bars indicating the effect of each treatment relative to baseline episodes per week.*

FDA Label Image

Mean Change (sd) In Episodes Per Week From Baseline (Oxybutynin Chloride 05)

A horizontal bar chart comparing the mean change in episodes per week from baseline for Oxybutynin Chloride and oxybutynin. The x-axis ranges from -40 to 40 and shows mean changes with standard deviation bars for each substance.*

FDA Label Image

Mean Change (sd) In Episodes Per Week From Baseline (Oxybutynin Chloride 06)

A horizontal bar chart showing mean change (±SD) in episodes per week from baseline for Oxybutynin Chloride and oxybutynin. The chart visually compares the reduction in episodes for each treatment group using bars with error bars representing standard deviation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.